Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients.

CONCLUSIONS: XRCC3Thr241Met and XRCC1Arg399Gln may be predictive of survival outcome in EBC patients treated with anthracycline-based chemotherapy regimens. PMID: 23740134 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23740134?dopt=Abstract

Source: Clinical Breast Cancer - June 6, 2013 Category: Cancer & Oncology Authors: Castro E, Olmos D, Garcia A, Cruz JJ, González-Sarmiento R Tags: Clin Transl Oncol Source Type: research